Volta Medical
Volta Medical is an AI-driven medtech company that develops FDA-cleared and CE-marked software (VX1, AF-Xplorer II) using spatio-temporal dispersion mapping to guide electrophysiologists during atrial fibrillation ablation procedures, serving hospitals and EP labs across Europe and the United States.
- Company typePrivate
- Founded2016
- HeadquartersMarseille, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Volta Medical does
Volta Medical is a French-founded medtech company (Marseille, 2016) developing AI-guided software to assist cardiac electrophysiologists during atrial fibrillation (AF) ablation procedures. Its core technology is proprietary spatio-temporal dispersion mapping, which analyzes intracardiac electrogram signals in real time to identify ablation targets in complex and persistent AF cases. The company markets two principal products: VOLTA VX1 (its initial FDA-cleared AI software for cardiac arrhythmias) and the current-generation AF-Xplorer II, which is FDA 510(k)-cleared and CE-marked, features high stability analysis, expanded catheter compatibility (including Medtronic's Sphere-9), and integrates with GE HealthCare's CardioLab AltiX AI.i EP recording system.
Volta generates revenue through hardware/medical-device sales of AF-Xplorer II systems and integrated software solutions delivered via its GE HealthCare channel partnership, with pricing negotiated quote-by-quote through enterprise field sales. Its primary customers are hospitals and electrophysiology departments treating AF patients, with end users being interventional cardiologists and cardiac electrophysiologists performing catheter ablations, particularly for persistent and recurrent cases where empirical strategies underperform.
The company is venture-backed (Series B of €36M in January 2023 led by Vensana Capital with Gilde Healthcare and Lightstone Ventures), holds a dual US (FDA) and EU (CE) regulatory footprint, and has established US operations in Providence, Rhode Island to support its November 2025 commercial US launch. Clinical evidence is the core commercial asset: the RESTART trial demonstrated 83% AF-freedom at 12 months after a single procedure, and the TAILORED-AF randomized trial (370 patients across Europe and US) achieved 88% AF-freedom versus 70% with standard pulmonary vein isolation — the first Level 1 evidence of improved efficacy for persistent AF in EP history.
Volta Medical firmographics
Firmographics- Name
- Volta Medical
- Legal name
- Volta Medical
- Website
- https://volta-medical.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Volta Medical is an AI-driven medtech company that develops FDA-cleared and CE-marked software (VX1, AF-Xplorer II) using spatio-temporal dispersion mapping to guide electrophysiologists during atrial fibrillation ablation procedures, serving hospitals and EP labs across Europe and the United States.
- Ownership category
- akta.pro rank
Volta Medical industry classification
Industry- Product category
- Cardiac Electrophysiology AI Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD)
- akta.pro secondary industry
- Electrophysiology (Heart Rhythm) (HLAKABAC)
Keywords
Where Volta Medical is headquartered
LocationHeadquarters
- HQ city
- Marseille
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Volta Medical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Revenue model
- Medical Device Sales: Sale of AI-powered medical devices and systems (VX1, AF-Xplorer II) to hospitals and electrophysiology departments for use in cardiac ablation procedures.
- Integrated Software Solutions: Revenue from integrated AI software solutions sold in partnership with GE HealthCare, combining proprietary AI mapping with third-party recording systems.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Volta Medical product offering
Product offeringCore offering
Volta Medical develops AI-powered software that assists electrophysiologists during catheter ablation procedures for atrial fibrillation. Its flagship Volta AF-Xplorer II system identifies spatio-temporal dispersed electrograms in real time, integrating with EP recording systems (GE HealthCare CardioLab) and supporting multiple catheter types to provide objective, AI-driven guidance for ablation target identification in complex and persistent AF cases.
Product overview
Volta Medical is a medtech company offering AI-guided electrophysiology software. Its portfolio centers on the AF-Xplorer II system (the current-generation product), which integrates with GE HealthCare's CardioLab recording platform and supports multiple catheter types including Medtronic's Sphere-9. An earlier version branded as VOLTA VX1 served as the initial FDA-cleared AI software for cardiac arrhythmias. Both products are built on spatio-temporal dispersion mapping AI to guide catheter ablation for atrial fibrillation.
Differentiator
Problem solved
Functional benefit
Brands
- VOLTA VX1: AI software for cardiac arrhythmias
- Volta AF-Xplorer II
- VX1
Products and services
- Volta AF-Xplorer II A next-generation AI-enhanced mapping solution that assists electrophysiologists in real-time assessment of complex atrial fibrillation by identifying spatio-temporal dispersed electrograms during catheter ablation procedures. Features high stability analysis, expanded catheter compatibility (including Medtronic Sphere-9), and integration with GE HealthCare's CardioLab AltiX AI.i recording system. FDA 510(k)-cleared and CE-marked.
- VOLTA VX1 AI software for cardiac arrhythmias designed to assist physicians in identifying dispersed electrograms during ablation procedures for atrial fibrillation. FDA 510(k)-cleared. The initial product that established Volta Medical's presence in AI-guided electrophysiology and drove the company's Series B funding.
Quantifiable outcome
- 83% freedom from atrial fibrillation at 12 months after single procedure (RESTART trial)
- +3 more outcomes
Companies that use Volta Medical
Customer profileSegments2 records
Ideal customer profiles2 records
Volta Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature3 records
Volta Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GE HealthCarecoreVolta Medical and GE HealthCare announced successful US launch of integrated AI-driven electrophysiology solutions, combining Volta's AF-Xplorer II system with GE HealthCare's CardioLab AltiX AI.i EP recording system. The integrated solution provides electrophysiologists with advanced signal clarity and AI-driven insights for complex atrial fibrillation ablation procedures.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Volta Medical competitors and assessment
Company assessmentBroad incumbents
- Biosense Webster (Johnson & Johnson): Johnson & Johnson's EP subsidiary and global market leader in cardiac ablation. Competes with Volta via the CARTO 3 electroanatomical mapping system and ablation catheters, and is the largest incumbent Volta must displace or partner with in EP labs.
- Abbott: Global medtech incumbent with the EnSite X EP mapping system and TactiFlex ablation catheter portfolio. Directly competes in AF ablation procedure guidance and has the installed-base and KOL relationships that define Volta's competitive set.
- Boston Scientific: Major EP player with the Rhythmia HDx mapping system and FARAPULSE pulsed-field ablation platform. Competes in the same AF ablation workflows as Volta and is rapidly expanding its AI-guided mapping capabilities.
- Medtronic: Global medtech leader in EP with the Sphere-9 catheter (which Volta's AF-Xplorer II is now compatible with) and Affera mapping/primo ablation system. Both a potential channel partner and a vertically integrated competitor in AI-guided AF ablation.
Others
- GE HealthCare: Volta's strategic integration partner for the CardioLab AltiX AI.i EP recording system. Comparable in that both serve electrophysiology labs with integrated hardware/software solutions, but operates as a complementary channel rather than a direct AI mapping competitor.
Direct peers
- Acutus Medical: EP-focused company developing mapping and ablation technologies for arrhythmia treatment. Directly comparable as an AI-enabled mapping competitor targeting similar electrophysiologist customers in catheter ablation.
Emerging players
- Kardium: Developer of the Globe Mapping and Ablation System for AF treatment. Targets the same AF ablation procedure workflow as Volta with a single-catheter mapping-and-ablation approach, addressing a partially overlapping customer base.
- Adagio Medical: Clinical-stage company developing pulsed-field and ultra-low-temperature cryoablation for persistent AF. Addresses the same persistent AF patient population where Volta's clinical evidence is strongest.
- Stereotaxis: Developer of robotic magnetic navigation systems for EP procedures. Adjacent competitor in the procedure-guidance layer of AF ablation, with potential to integrate or compete with AI mapping software.
- CathVision: Developer of the ECGenius electrophysiology recording and AI analysis system. Targets similar electrophysiologist customers with AI-augmented signal interpretation, though more focused on recording than mapping/guidance.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
Volta Medical social profiles
Digital presenceVolta Medical compliance and trust
Trust signalCompliance2 records
Volta Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Volta Medical leadership team
Management profileNumber of profiles
Profiles3 records
Volta Medical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Volta Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Volta Medical
What does Volta Medical do?
Volta Medical develops AI-powered software that assists electrophysiologists during catheter ablation procedures for atrial fibrillation. Its flagship Volta AF-Xplorer II system identifies spatio-temporal dispersed electrograms in real time, integrating with EP recording systems (GE HealthCare CardioLab) and supporting multiple catheter types to provide objective, AI-driven guidance for ablation target identification in complex and persistent AF cases.
Is Volta Medical a public or private company?
Volta Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Volta Medical founded?
Volta Medical was founded in 2016. It employs 51 to 100 people.
Where is Volta Medical based?
Volta Medical is headquartered in Marseille, France, in the Europe region.
How does Volta Medical make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are integrated Software Solutions.
Who are Volta Medical's main competitors?
Broad incumbents on record are Biosense Webster (Johnson & Johnson), Abbott, Boston Scientific and Medtronic. GE HealthCare is listed as an others. Acutus Medical is listed as a direct peer. Emerging players are Kardium, Adagio Medical, Stereotaxis and CathVision.
Does Volta Medical have an API?
No public API is recorded for Volta Medical.
What industry is Volta Medical in?
Volta Medical's product category is Cardiac Electrophysiology AI Software. Its primary akta.pro industry code is HLAHAFAD, Electrophysiology Mapping & Ablation Systems, with a secondary code of HLAKABAC, Electrophysiology (Heart Rhythm). Its NAICS code is 334510 and its SIC code is 3845.